Evidence map›Paper›PMID 29450981›Full record

ArticleCNS neuroscience & therapeutics2018

Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia.

Xiao-Xiang Chen, Yuan Qian, Xiang-Peng Wang, Zhi-Wei Tang, Jiao-Tian Xu, Hai Lin, Zhi-Yong Yang, Xiao-Bin Song, Di Lu, Jia-Zhi Guo and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Xiao-Xiang ChenDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.ORCID 0000-0003-4768-0907
Yuan QianGenetic Diagnosis Center, Kunming City Women and Children Hospital, Kunming, Yunnan, China.
Xiang-Peng WangDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zhi-Wei TangDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Jiao-Tian XuDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Hai LinDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Zhi-Yong YangDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Xiao-Bin SongDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Di LuRehabilitation Engineering Research Laboratory, Biomedicine Engineering Research Centre, Kunming Medical University, Kunming, Yunnan, China.
Jia-Zhi GuoRehabilitation Engineering Research Laboratory, Biomedicine Engineering Research Centre, Kunming Medical University, Kunming, Yunnan, China.
Li-Gong BianDepartment of Anatomy, Kunming Medical University, Kunming, Yunnan, China.
Yu LiDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Lei ZhouThe Key Laboratory of Stem Cell and Regenerative Medicine of Yunnan Province, Institute of Molecular and Clinical Medicine, Kunming Medical University, Kunming, China.
Xing-Li DengDepartment of Neurosurgery, 1st Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNeural stem cells (NSCs) are the most promising cells for cell replacement therapy for Parkinson's disease (PD). However, a majority of the transplanted NSCs differentiated into glial cells, thereby limiting the clinical application. Previous studies indicated that chronic neuroinflammation plays a vital role in the degeneration of midbrain DA (mDA) neurons, which suggested the developing potential of therapies for PD by targeting the inflammatory processes. Thus, Nurr1 (nuclear receptor-related factor 1), a transcription factor, has been referred to play a pivotal role in both the differentiation of dopaminergic neurons in embryonic stages and the maintenance of the dopaminergic phenotype throughout life.

aimThis study investigated the effect of Nurr1 on neuroinflammation and differentiation of NSCs cocultured with primary microglia in the transwell coculture system.

resultsThe results showed that Nurr1 exerted anti-inflammatory effects and promoted the differentiation of NSCs into dopaminergic neurons.

conclusionsThe results suggested that Nurr1 protects dopaminergic neurons from neuroinflammation insults by limiting the production of neurotoxic mediators by microglia and maintain the survival of transplanted NSCs. These phenomena provided a new theoretical and experimental foundation for the transplantation of Nurr1-overexpressed NSCs as a potential treatment of PD.

Indexed as

AnimalsAnimals, NewbornCell DifferentiationCells, CulturedCoculture TechniquesDopaminergic NeuronsHEK293 CellsHumansInflammation MediatorsMicrogliaNeural Stem CellsNeurogenesisNuclear Receptor Subfamily 4, Group A, Member 2RatsRats, Sprague-DawleyInflammation MediatorsNr4a2 protein, ratNuclear Receptor Subfamily 4, Group A, Member 2cocultureinflammatorymicroglianeural stem cellsNurr1

Identifiers

PMID29450981
PMCPMC6489950
OpenAlexW2791558040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.